International Conference of Frailty and Sarcopenia Research 2025

March 14, 2025 | Toulouse, FR

Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX.

“Novel Senolytic Peptides Alleviate Sarcopenia And Frailty In Naturally Aged Mice By Targeting Senescent Cells”

International Conference of Frailty and Sarcopenia Research 2025 – oral communication on the plenary session of the International Conference of Frailty and Sarcopenia Research 2025

Plenary Session OC29
8 A.M. EST

Registration